AbClon

174900 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

AbClon updated a previously disclosed supply contract, now worth US$313K, about 9% of its recent annual revenue, running through Nov 2026.

Supply contract([Amended] Supply contract signed (voluntary))· FILED 2026-09-30· RCEPT 20260930900401

US$313KContract value
9%vs. recent revenue
Nov 2026Throughfrom May 2026

Converted at 1 USD ≈ ₩1,356.84 (filing-date rate, 2026-09-30 close)

What happened

AbClon updated a previously disclosed supply contract, now worth US$313K, about 9% of its recent annual revenue, running through Nov 2026.

For context, this single contract equals about 9% of the company's most recent annual revenue.

CounterpartyDisclosed
Contract valueUS$313K
vs. recent revenue9%
ThroughNov 2026 (from May 2026)
Filed2026-09-30, [Amended] Supply contract signed (voluntary)
SourceDART rcept 20260930900401 → open original filing

Versions of this filing

  1. 2026-05-21Original
  2. 2026-07-31Amendment 1
  3. 2026-09-30Amendment 2 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-30 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.